Novartis AG
![Novartis AG](https://api.admiralmarkets.com/trade_icons/bright-128/NVS.png)
Closed
116.68 0.16
Overview
Share price change
24h
Min
116.6
Max
116.9
Income | 2.7B |
---|---|
Sales | 344M 12B |
P/E Sector Avg | 23.59 103.001 |
EPS | 1.31 |
Profit margin | 22.178 |
EBITDA | 4.7B |
Recommendations | Neutral |
---|---|
12 Months Forecast | +0.35 upside |
Market Cap | 818M 247B |
---|---|
Previous open | 116.52 |
Previous close | 116.68 |
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Novartis AG Chart
Related News
Peer Comparison
Price change
Novartis AG Forecast
Price Target
By TipRanks
0.35% upside
12 Months Forecast
Average 116.9 USD 0.35%
High 125 USD
Low 97 USD
Based on 6 Wall Street analysts offering 12 month price targets forNovartis AG - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Novartis AG
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.